Interrogation of best SNPs with the smallest p-value within known EA loci in AA for trait WHR ratio adjusted for BMI.

<p>The index SNPs are from Heid et al, Nature Genetics 2010 <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003681#pgen.1003681-Heid1" target="_blank">[17]</a>. Note that <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003681#pgen-1003681-t003" target="_blank"><b>Tables 3</b></a> and <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003681#pgen-1003681-t004" target="_blank"><b>4</b></a> show different information for the same loci (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003681#pgen-1003681-t003" target="_blank"><b>Table 3</b></a> for index SNP and <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003681#pgen-1003681-t004" target="_blank"><b>Table 4</b></a> for best SNPs with the smallest p-value).</p>1<p>effect allele/other allele.</p>2<p>effect allele frequency.</p>3<p>number of independent (typed) SNPs interrogated in AA sample.</p>4<p>Bonferroni p-value threshold (0.05/N³).</p>5<p>HapMAP LD information.</p>6<p>one-side test p-value.</p>7<p>P_2GC: double GC-corrected p-value.</p

Cross-trait associations for novel loci from Stage1 + Stage 2 in participants of African ancestry.

1<p>effect allele/other allele.</p>2<p>effect size based on Stage 1 and Stage 2 combined sample.</p

Examination of index SNPs within known loci in EA in AA for trait WHR ratio adjusted for BMI.

<p>The index SNPs is from Heid et al, Nature Genetics 2010 <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003681#pgen.1003681-Heid1" target="_blank">[17]</a>.</p>1<p>effect allele/other allele.</p>2<p>effect allele frequency.</p>3<p>Significance classification refers to the interrogation results of best SNP in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003681#pgen-1003681-t004" target="_blank"><b>Table 4</b></a>.</p>4<p>p-value of heterogeneity test of beta between EA and AA samples.</p

Interrogation of the six novel loci uncovered in the European ancestry (EA) individuals (CKDGen consortium) in individuals of African ancestry (AA) from the CARe consortium for the trait eGFRcrea.

<p>Ref./Non-Ref. All.: reference/non-reference alleles; RAF: reference allele frequency; SE: standard error.</p>*<p>Characteristics of the six lead SNPs in the EA individuals from the CKDGen consortium can be found in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1002584#pgen-1002584-t001" target="_blank">Table 1</a>.</p>§<p>The gene closest to the SNP is listed first and is in boldface if the SNP is located within the gene.</p>**<p>S = number of independent, typed SNPs interrogated.</p>†<p>No LD information available in the HapMap database between the target SNP and the best SNP in the DDX1 region.</p>‡<p>The SNP rs11078903 was not present in the CARe consortium database.</p

Novel loci associated with eGFRcrea.

<p>SNPs are listed in the stratum where the smallest <i>P</i> value in the discovery analysis was observed. Sample size/number of studies in the discovery phase: 74,354/26 (overall, direction test), 66,931/24 (No Diabetes), 46,435/23 (age ≤65 years); replication phase: 56,246/19 (overall, direction test), 41,218/17 (No Diabetes), 28,631/16 (age ≤65 years); combined analysis: 130,600/45 (overall, direction test), 108,149/41 (No Diabetes), 75,066/39 (age ≤65 years).</p><p>Chr.: chromosome; bp: base-pairs; Ref./Non-Ref. All.: reference/non-reference alleles; RAF: reference allele frequency; SE: standard error.</p>‡<p>Genes nearby were based on RefSeq genes (build 36). The gene closest to the SNP is listed first and is in boldface if the SNP is located within the gene.</p>§<p>Effects on log(eGFRcrea); post GWAS meta-analysis genomic control correction applied to <i>P</i> values and SEs.</p>*<p>While being uncovered in the younger samples, this locus showed consistent results in the non-diabetic group (combined-analysis <i>P</i> value 5.7×10⁻¹⁶) and in the overall population (<i>P</i> value 9.5×10⁻²²) - see <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1002584#pgen.1002584.s028" target="_blank">Tables S16</a> and <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1002584#pgen.1002584.s022" target="_blank">S10</a> for additional details.</p>**<p>The direction test was performed in the overall dataset; the genomic control corrected <i>P</i> value from the direction test for the SNP rs2928148 was 4.0×10⁻⁷. In the combined analysis, the largest effect size (0.0054 on log eGFR in ml/min/1.73 m²) and the smallest <i>P</i> value (3.7×10⁻⁸) were observed in the non-diabetic group.</p>†<p>All results were confirmed by random-effect meta-analysis.</p